Try our new research platform with insights from 80,000+ expert users
IBM Security Guardium Data Protection Logo

IBM Security Guardium Data Protection Reviews

Vendor: IBM
4.1 out of 5
Badge Ranked 1
1,434 followers
Post review

What is IBM Security Guardium Data Protection?

Featured reviews

IBM Security Guardium Data Protection mindshare

As of December 2024, the mindshare of IBM Security Guardium Data Protection in the Database Security category stands at 32.3%, up from 29.9% compared to the previous year, according to calculations based on PeerSpot user engagement data.
Database Security

PeerAnalyst reports

TypeTitleDate
CategoryDatabase SecurityDec 27, 2024Download
ProductReviews, tips, and advice from real usersDec 27, 2024Download
ComparisonIBM Security Guardium Data Protection vs Imperva SecureSphere Database SecurityDec 27, 2024Download
ComparisonIBM Security Guardium Data Protection vs Oracle Audit VaultDec 27, 2024Download
ComparisonIBM Security Guardium Data Protection vs Trustwave DbProtectDec 27, 2024Download
Suggested products
TitleRatingMindshareRecommending
Imperva SecureSphere Database Security4.130.6%92%55 interviewsAdd to research
Cyera4.31.6%100%2 interviewsAdd to research
 
 
Key learnings from peers

Valuable Features

Valuable Features

Room for Improvement

Room for Improvement

ROI

Pricing

Pricing

Popular Use Cases

Deployment

Scalability

Review data by company size

By reviewers
By visitors reading reviews

Top industries

By visitors reading reviews
Financial Services Firm
30%
Computer Software Company
12%
Manufacturing Company
7%
Government
7%
Insurance Company
7%
Retailer
3%
University
3%
Healthcare Company
3%
Hospitality Company
3%
Educational Organization
3%
Real Estate/Law Firm
2%
Construction Company
2%
Media Company
2%
Comms Service Provider
2%
Non Profit
2%
Transportation Company
2%
Logistics Company
1%
Energy/Utilities Company
1%
Aerospace/Defense Firm
1%
Legal Firm
1%
Recreational Facilities/Services Company
1%
Wholesaler/Distributor
1%
Consumer Goods Company
1%
Pharma/Biotech Company
1%
Performing Arts
1%